Articles related to Cardiology, Interventional

This CME program is dedicated to exploring the integration of artificial intelligence in the field of cardiology, focusing on its application for diagnosis, clinical decision support, and improving the quality of patient care.

With FDA-approved features in wearable devices for heart health monitoring and the advent of home test kits for conditions like anemia, clinicians now have innovative tools at their disposal to enhance patient care and autonomy.

Stella’s case, entwining severe addiction with critical health conditions, underscores the pressing need for a healthcare approach that transcends traditional biases and embraces comprehensive, compassionate care.

In the landscape of cardiac monitoring, consumer-grade smart devices have shown a remarkable ability to detect atrial fibrillation with high sensitivity and specificity, challenging the traditional reliance on medical-grade monitoring tools.

In this pivotal trial, apixaban, when used for subclinical atrial fibrillation, demonstrated a 0.63 hazard ratio for stroke or systemic embolism compared to aspirin, indicating a significant reduction in stroke risk at the expense of increased bleeding risk.

In light of recent findings, medical professionals should consider that while liberal transfusion strategies in myocardial infarction patients with anemia do not substantially decrease the risk of further myocardial infarction or death, the restrictive approach’s potential harms should not be overlooked.